Condition: Biofilms · Arterial Catheterization, Peripheral · Bacteremia · Sponsor: Centre Hospitalier William Morey - Chalon sur Saône
29.3% of bacteremias in intensive care units (ICU) are linked to vascular devices, including 7.7% to arterial catheters, with an influence on both morbility and mortality. It is now accepted that biofilm as a role on bacterial development on inner surface of vascular devices but there is yet a lack of clinical relevant data documenting a causal relation between biofilm formation and bacteremias. The investigators assume that a better structural and microbiological characterization of arterial catheter biofilm in ICU patients could help preventing bacteremias or have a more specific treatment when it appears.
This description comes directly from the study's public registry record.
Florian PERRAUD · 06 78 58 85 19 · florian.perraud@ch-chalon.fr
Thomas MALDINEY · thomas.maldiney@ch-chalon.fr
Always discuss trial participation with your own doctor first.
| CHU Dijon Bourgogne | Dijon, Bourgogne-Franche-Comté, France | Recruiting |
| CH Macon | Mâcon, Bourgogne-Franche-Comté, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06838598